Purdue Pharma Acquires Shire’s OTC Portfolio for US$72 M

By Business Review Editor

Pharma Deals Review: Vol 2003 Issue 32 (Table of Contents)

Published: 3 Jan-2003

DOI: 10.3833/pdr.v2003.i32.960     ISSN: 1756-7874

Section: Distribution & Marketing

Fulltext:

Abstract

Purdue Pharma acquired the portfolio of over-the counter (OTC) products of Shire’s Pharmaceuticals for US$72 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details